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 ABSTRACT 
 
Published reports of extremely preterm birth outcomes provide important information to 
families, clinicians, and others and are widely used to make clinical and policy decisions. 
Misreporting or misunderstanding of outcome reports may have significant consequences. This 
article presents seven recommendations to improve reporting of extremely preterm birth 
outcomes in both the primary and secondary literature. The recommendations should facilitate 
clarity in communication about extremely preterm birth outcomes and increase the value of 
existing and future work in this area.  
 
 
 
Abstract word count: 79  
 BACKGROUND 
 
Extremely preterm births constitute a small proportion of all worldwide births but a large portion 
of perinatal death and morbidity.
1,2
 They are a heterogeneous group with a wide range of 
potential outcomes—the probability of infant survival ranging from 0% to >80% in the setting of 
modern intensive obstetric and neonatal care.
3
 
 
Clinicians who care for families facing extremely preterm birth require accurate prognostic 
information to counsel families about what to expect and inform clinical decision making. 
However, prognostic data are important well beyond the period immediately preceding and 
following delivery. Survival following extremely preterm birth has improved in recent decades,
4-
8
 and clinicians of various specialties are now more likely than ever to care for survivors in all 
stages of their lives.
9
 Moreover, policy makers, administrators, researchers and others require 
information on extremely preterm birth outcomes in order to plan for the delivery of medical 
care, education, and other services and to improve how such services are provided. 
 
For these reasons and others (Table 1), large studies of infant outcomes following extremely 
preterm birth have been performed around the world, often at great public expense.
10
 To increase 
their value and to avoid waste, it is imperative that such studies are not only well conducted but 
are also accurately reported and in ways that encourage comparability across studies.
11,12
 The 
need for proper reporting applies to both primary research and secondary reports, such as popular 
media, reviews, and practice guidelines. 
 
 In this article, we provide recommendations for reporting outcomes of extremely preterm births. 
This list of practices is not intended to be comprehensive but highlights several issues related to 
reporting that are commonly overlooked.
13
 We believe that following these few simple practices 
should reduce bias and increase the value of outcome data for families, clinicians, and society. 
 
RECOMMENDATIONS 
 
Good research starts with meaningful and important questions, and research reporting should 
reflect this. A well-composed question about extremely preterm birth outcomes should include a 
specific: a) patient population, b) set of “exposures” (i.e., factors that may affect the outcome), 
and c) outcome (or set of outcomes).
14 
Our recommendations address each of these aspects 
separately. 
 
A. Population: 
 
Important considerations in extremely preterm birth outcome reporting include describing the 
study’s source population and defining the study’s inception point. 
 
Recommendation #1: Describe the source population 
Birth outcomes should be reported with information on the setting in which the data were 
collected. Such information informs how data are interpreted and applied. Given changes in 
medical care over the past two decades, outcome data for extremely preterm births in 1995 may 
not wholly predict outcomes for births in 2016. Similarly, data from a low-resource setting may 
 not be applicable to a well-resourced one. Reports of extremely preterm birth outcomes should 
include dates, geographic location, and any other information important to understanding the 
context of the study.  
 
Studies of extremely preterm births generally report outcomes from single centers, multicenter 
networks, or geographically defined areas. Because hospital level of maternal and newborn care 
is associated with the likelihood of infant survival,
15,16
 geographically defined studies (i.e., those 
that include both community and referral hospitals as well as births outside of hospitals) are 
likely to produce outcomes that are different than outcomes from studies of single referral 
hospitals or networks of referral hospitals. The latter studies do not include infants who died 
prior to transfer to a higher level of care or that were healthy enough to avoid transfer altogether. 
A study’s source population – whether single center, multicenter, or geographically defined – 
should be clearly specified. 
 
Of note, the appropriateness of a study’s source population depends on the question asked or 
decision to be made with the data. To provide prognostic information to the family of an infant 
born in a hospital providing highly specialized maternal and newborn care (e.g., with a level 3 or 
4 neonatal intensive care unit),
17
 statistics from that or similar units are preferred. However, for a 
policymaker concerned about resource allocation or a researcher interested in the effects of care 
regionalization, geographically defined studies provide the most appropriate information on 
these topics. Comparing birth outcomes from geographically defined studies (that include 
community hospitals and out-of-hospital births) to outcomes from tertiary care centers, without 
appropriate stratification, is uninformative and should be avoided. 
 Recommendation #2: Define a study’s inception point 
Related to a study’s source population is its inception point. Studies of extremely preterm births 
vary in the point at which researchers begin to observe outcomes. Studies may collect data for all 
births (including intrapartum and antepartum stillbirths),
5
 all fetuses alive at presentation to the 
hospital
18
 (or at the onset of labor
19
), all live births,
7
 or for only those infants who survive to 
admission to the neonatal intensive care unit.
20
 
 
A study’s inception point influences outcome statistics.21 Survival among infants admitted to the 
neonatal intensive care unit will be higher than survival for all liveborn infants, as the former 
excludes deaths that took place in the delivery room. Likewise, survival for live births will be 
higher than for fetuses alive at the onset of labor as the former excludes intrapartum stillbirths.
22
  
 
As with a study’s source population, the questions asked or decisions to be made should 
determine the appropriate inception point. For example, outcomes data intended for making 
decisions related to an impending extremely preterm birth should include the possibility of 
intrapartum stillbirth. Data used to answer questions about outcomes after admission to a 
neonatal intensive care unit should convey the relevant outcomes beginning at that point.  
 
Studies should avoid reporting mixed inception points. For example, one study reported 
outcomes for all liveborn infants born at 22 or 23 weeks’ gestation at 48 tertiary care hospitals 
(including those that died in the delivery room) together with outcomes for infants transferred to 
those hospitals from an outside hospital within 28 days following birth (therefore excluding 
infants who died prior to potential transfer or who survived without transfer).
23
 Statistics based 
 on such a mixed group are difficult to meaningfully apply to any particular question or decision. 
 
B. Exposures 
 
Because of their significant impact on birth outcomes and on decisions made surrounding birth, 
we recommend that studies reporting extremely preterm birth outcomes take into account at least 
two factors: gestational age at birth and whether perinatal treatment was directed toward survival 
or palliation. 
 
Recommendation #3: Stratify outcomes by gestational age at birth 
Although other factors affect the outcome of extremely preterm birth, the duration of fetal 
maturation is among the most important.
24
 Infants born at 20 weeks’ gestation are too immature 
to survive while, in many places, the majority of infants born at 25 weeks’ gestation survive. 
Moreover, many hospitals,
25
 professional societies,
26
 and countries
27
 have developed policies 
surrounding medical care based on gestational age.  
 
Importantly, the margin of error for gestational age estimation may vary depending on its 
timing.
28,29
 Whenever possible, the best obstetric estimate (preferably based on first-trimester 
ultrasound) should be used to characterize infant gestational age. 
 
Reports that lump together births across multiple gestational ages (e.g., 22-25 weeks) may 
obscure important information. For example, in the EXPRESS study, which included births from 
across Sweden from 2004 to 2007, the average rate of 1-year survival for 501 infants born alive 
 at 22-25 weeks’ gestation was 64%.8 However, of the 51 infants born at 22 weeks 10% survived, 
and of the 205 born at 25 weeks, 81% survived. The average for infants born at 22-25 weeks 
conceals substantial differences in outcomes. When possible, primary reports of extremely 
preterm birth outcomes should stratify by gestational age week or smaller units.
30
  
 
Of note, many factors beyond gestational age may affect extremely preterm birth outcomes. Due 
to the influence of factors such as infant birth weight, infant sex, antenatal corticosteroids, and 
plurality (i.e., being a twin, triplet, etc), the rate of survival for certain subgroups of infants born 
at 22 weeks’ gestation is higher than the rate for other subgroups of infants born at 25 weeks’ 
gestation.
24,31
 Small sample sizes limit the ability of many studies to report on subgroups beyond 
gestational age. However, when studies are large enough, authors may consider reporting 
outcomes across multiple variables including gestational age. Multivariable modeling provides 
one potential approach for taking into account several prognostic factors simultaneously.
24,32
 
 
Recommendation #4: Report on decisions regarding treatment 
Decisions surrounding treatment for extremely preterm birth impact infant outcomes directly and 
should be accounted for in all reports. The willingness of an obstetrician to provide a cesarean 
section has been shown to correlate with whether delivery results in live birth or stillbirth,
33
 and 
large variations in rates of live birth and stillbirth have been shown among countries,
34
 within-
country regions,
35
 and even hospitals within the same city.
36
 Moreover, whether liveborn infants 
are resuscitated after birth influences survival statistics, and decisions to resuscitate may vary 
widely across countries
37
 and among tertiary care centers within the same country.
38
 
 
 Defining decisions about treatment presents logistic difficulties, but several approaches have 
been attempted. Bottoms et al collected data directly on obstetricians’ and neonatologists’ 
impressions of fetal viability.
19
 Serenius et al developed an ordinal scale to capture varying 
degrees of obstetric and neonatal care.
39
 Other studies have simply identified whether intensive 
care, as a binary (yes/no) variable, was provided after birth.
5,24,38 
The appropriate approach 
depends on the question to be answered with the data. 
 
To include in reported statistics both birth outcomes following active treatment and birth 
outcomes that resulted from not initiating active treatment, without distinguishing between the 
two, results in significant bias.
38,40,41
 Outcome data for extremely preterm births where life-
sustaining treatment was withheld (where palliation was the intended goal) should not be used to 
infer the probability of a good outcome for a birth where life-sustaining treatment is intended. 
Outcomes for births where active treatment is intended should be reported separately.
42
 This 
issue is particularly relevant for births at 22, 23, and 24 weeks of gestation, where the provision 
of active treatment is most variable.
37,38
 
 
C. Outcomes 
 
Study outcomes should be well-defined, relevant to study users, and reported with information 
regarding their accuracy and precision.   
 
Recommendation #5: Describe outcome definitions 
Outcomes reported from extremely preterm birth studies should be meaningful to families, 
 clinicians, and society. The most useful outcomes may be those that are developed a priori and 
in collaboration with families or other stakeholders who will use the data.  
 
When reporting on composite outcomes such as “neurodevelopmental impairment” or “severe 
morbidity,” both aggregate and component outcomes should be clearly defined. Both primary 
and secondary reports should avoid mixing or comparing outcomes of varying relevance to 
families, clinicians, and society. Where composite outcomes are necessary, such as with 
competing outcomes (i.e., where one outcome, such as mortality, precludes the possibility of 
other outcomes, such as developmental delay, blindness or deafness at 2 years’ corrected age), 
primary reports should also present data for each component outcome.  
 
Importantly, short-term morbidities should not be equated with long-term sequelae of 
prematurity in composite outcomes or when making comparisons among studies. Many infants 
who experience short-term morbidities have no resulting long-term health issues and vice 
versa.
43,44
 Special care should be taken when making comparisons among studies, as morbidities 
are often defined differently. Use of standardized definitions (such as those of the British 
Association of Perinatal Medicine) facilitates the comparison of outcomes across studies.
45,46
 
 
Measurement of outcomes using developmental scores requires an appropriate reference group 
and studies differ in their selection of references. Standardized assessments such as the Bayley 
Scales of Infant and Toddler Development may be compared to historical normative reference 
data or to data from a concurrent term-born comparison group. The use of a term-born 
comparison group similar to the preterm population with term and preterm status blinded to the 
 assessor may strengthen the relevance of developmental assessments and reduces the potential 
for expectation bias (i.e., where preconceptions about outcomes at early gestational ages 
influence the assessment).
47,48
 
 
Recommendation #6: Describe the timing of outcome assessment 
The time at which an outcome is assessed (e.g., at 28 days after birth, at discharge, or at 5 years’ 
corrected age) should be clearly reported as part of the outcome definition. Rates of both survival 
and morbidity vary depending upon the timing of outcome measurement. Developmental 
outcomes, in particular, vary over time, as some children may “catch up” with their peers 
whereas other deficits may only become apparent at later ages.
49,50
 
 
An additional controversy related to the timing of outcomes concerns whether or not to correct 
age for the degree of prematurity. Outcomes may be reported by chronological age (i.e., the time 
since birth) or by “corrected age” (i.e., the time since the expected due date).51 A recent study 
demonstrated a persistent clinically important bias in cognitive test scores when age was not 
corrected for prematurity even into the teenage years.
52
 
 
Primary reports should report the number of participants for whom data were not available at the 
time of assessment. They should report on differences between the participants with and without 
follow-up data available in order to convey whether the group with known outcomes is 
representative of the original cohort.
53
 
 
 
 Recommendation #7: Report the statistical uncertainty of the outcome 
Many studies of extremely preterm birth report outcomes such as survival or 
“neurodevelopmental impairment” as proportions. These outcomes represent the number of 
individuals with an outcome (the numerator) from a specified group (the denominator)—for 
example, 1169 of 2034 (57%) infants born alive at 22-26 weeks’ gestation survived to 28 days.5 
In some cases, outcomes are reported on a numeric scale (e.g., hemoglobin concentration of 12.6 
g/dL or 1-minute Apgar score of 3) or as counts of recurring events (e.g., average number of 
emergency room visits per child during the first two years of life).  
 
When reporting outcomes of extremely preterm births, which often involve small numbers, it is 
critical to convey the precision of the outcome estimate. Because larger sample sizes confer a 
more statistically precise estimate, reports should include information on both the number of 
infants included in the denominator of the statistic and a 95% confidence interval of the estimate. 
For example, if 33% of infants born at 23 weeks’ gestation survived, it is important to indicate 
whether 33% (95% CI: 16-56%) of 18 infants survived, 33% (95% CI: 28-39%) of 300 infants 
survived, or 33% (95% CI: 31-36%) of 1200 infants survived. Clearly, the last estimate is much 
more precise than the first; with only 18 infants, the 95% confidence interval includes rates both 
half and nearly twice as large as the point estimate of 33%. Information on the precision of 
outcome estimates is critical to making informed decisions and to comparing outcomes between 
studies.  
 
  
 CONCLUSIONS 
 
Using a more standardized approach to report extremely preterm birth outcomes will facilitate 
clarity in communication about outcomes and increase the value of existing and future data.  
 
Our recommendations (Table 2), which draw attention to issues related to outcome reporting for 
extremely preterm births, accord with existing and more general guidelines for reporting clinical 
outcomes. Guidelines for primary reports of observational studies (e.g., Strengthening the 
Reporting of Observational Studies in Epidemiology [STROBE]
54
) or for reviews
55
 and meta-
analyses of prognosis statistics (e.g., those in development by the Cochrane Methods Prognosis 
Group
56
) should be used where applicable to promote accurate and complete reporting. 
 
Although issues surrounding the reporting of extremely preterm birth outcomes are in many 
ways unique, many of the practices listed above could be used to improve outcome reporting for 
other perinatal conditions, such as hypoxic-ischemic encephalopathy
57
 or congenital 
diaphragmatic hernia
58
, where similar issues of small sample size and wide variation in treatment 
occur.  
 
Accurate information about extremely preterm birth outcomes is critical for making informed 
judgments about medical care. Such data can inform us about the success and failure of our 
efforts and guide our understanding of where further research is required. We owe it to patients 
and families, who participate in studies of extremely preterm birth outcomes, and to the public, 
who fund many such studies, to provide accurate, transparent reports of outcomes in the primary 
 and secondary literature. Following the above-listed practices may help to increase the 
usefulness of outcome statistics for extremely preterm births, avoid bias and waste, and allow 
families, clinicians, and the public-at-large to make better informed decisions. 
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 TABLE 1. Uses of Extremely Preterm Birth Outcome Data 
 
Counseling and decision-making before and after birth 
Preparing survivors and caregivers for what to expect across the life-course 
Planning for services and allocating resources 
Benchmarking hospital or regional outcomes 
Identifying research questions and hypotheses 
 
 
TABLE 2. Recommendations for Reporting Extremely Preterm Birth Outcomes 
 
Recommendation Specific Example 
1. Describe the source population Report the study dates and location. Define 
whether geographically based, single center, or 
multicenter.  
2. Define the study’s inception point Report statistics from a time point relevant to a 
specific question or decision (e.g., for counseling 
when presenting to the hospital in labor, include all 
fetuses alive at presentation to the hospital). Avoid 
combining multiple time points. 
3. Stratify outcomes by gestational 
age 
Report outcomes by gestational age week. Larger 
studies may include other relevant subgroups. 
4. Report on decisions regarding 
treatment 
Report outcomes for births where active treatment 
is intended separately from those where it was not. 
5. Describe outcome definitions Describe the components of outcomes such as 
“neurodevelopmental impairment” or “severe 
morbidity.” Avoid combining outcomes of varying 
relevance. 
6. Describe the timing of the 
outcome assessment 
Report the time at which outcomes were obtained 
and the number of participants for whom outcomes 
were available. 
7. Report the statistical uncertainty 
of the outcome 
Include 95% CIs and denominator sizes (n's) for 
statistics. 
 
